Pension funds urge new direction in pharmaceuticals

[16:00 CET 26-02] GLOBAL – Pharmaceutical firms operating in emerging markets regions offer huge investment potential for the future, but business models need to be adapted to the local environment and could in turn require new longer-term financing structures, suggests a study conducted by two major European pension funds.

You have now reached your article limit

Already a registered user or member? Sign in here

To continue reading, register free today for access

Register Now

Registration also includes access to

IPE Real Assets

Gated access promo

Five reasons to register today

  1. Access to IPE articles from our award-winning editorial team
  2. Unique IPE market data, rankings and tables
  3. In-depth interviews with pension fund leaders
  4. Extensive coverage of latest asset class trends
  5. Comprehensive archive of data, research and intelligence